Skip to main content

Grafa News and Videos — Page 1582

Latest

Grafa

Novo Nordisk challenges Eli Lilly with data claiming superiority in oral obesity market

Novo Nordisk (NYSE:NVO) has intensified its rivalry with Eli Lilly (NYSE:LLY), releasing a provocative cross-trial analysis that claims its experimental Wegovy pill is both more effective and better tolerated than Lilly’s recently approved obesity tablet, Foundayo.

Read more: Novo Nordisk challenges Eli Lilly with data claiming superiority in oral obesity market
Grafa
Auto and cars

Tesla deliveries miss estimates as massive production gap signals waning demand

Tesla (NASDAQ:TSLA) reported first-quarter delivery numbers that fell short of Wall Street expectations, raising fresh concerns about a widening gap between the electric vehicle maker's manufacturing pace and global consumer appetite.

Read more: Tesla deliveries miss estimates as massive production gap signals waning demand
Grafa
Technology

Innovative Aerosystems expands general aviation footprint with Honeywell Avionics deal

Innovative Aerosystems (NASDAQ:ISSC) has reached an agreement with Honeywell International (NASDAQ:HON) to acquire key assets and intellectual property for select legacy avionics lines, a move that deepens the company’s reach into the global general aviation market.

Read more: Innovative Aerosystems expands general aviation footprint with Honeywell Avionics deal
Grafa

Merck’s Keytruda gains EU approval as first PD-1 therapy for hard-to-treat ovarian cancer

Merck (NYSE:MRK) has secured a landmark regulatory approval in the European Union for its blockbuster immunotherapy Keytruda, marking the region’s first PD-1 inhibitor authorized to treat a particularly aggressive form of ovarian cancer.

Read more: Merck’s Keytruda gains EU approval as first PD-1 therapy for hard-to-treat ovarian cancer

GET YOUR GRAFA EDGE NOW

We'll switch on a 30-day Edge trial as a welcome gift